ADMA Biologics
Stock Forecast, Prediction & Price Target
ADMA Biologics (ADMA) stock Price Target by analysts
$18
Potential upside: 2.97%
ADMA Biologics price prediction
What is ADMA Biologics stock analysts` prediction?
ADMA Biologics stock forecast: Based on 1 Wall Street analysts` predicted price targets for ADMA Biologics in the last 3 months, the avarage price target is $18, with a high forecast of $NaN. The average price target represents a 2.97% change from the last price of $17.48.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
ADMA Biologics stock Price Target by analysts
Full breakdown of analysts given ADMA Biologics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Raghuram Selvaraju H.C. Wainwright | 0% 0/1 | 11 months ago | $18 2.97% upside | $17.15 | StreetInsider | Previous targets (0) |
Anthony Petrone Mizuho Securities | 0% 0/1 | about 1 year ago | $14 -19.90% downside | $10.62 | StreetInsider | Previous targets (0) |
Unknown H.C. Wainwright | N/A | over 2 years ago | $4.5 -74.25% downside | $3.88 | Benzinga | N/A |
Unknown H.C. Wainwright | N/A | about 3 years ago | $4 -77.11% downside | $2.17 | Benzinga | N/A |
ADMA Biologics Financial Estimates
ADMA Biologics Revenue Estimates
ADMA Biologics EBITDA Estimates
ADMA Biologics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $80.94M N/A | $154.07M 90.35% | $258.21M 67.58% | Avg: $414.47M Low: $377.65M High: $451.29M avg. 60.51% | Avg: $471.63M Low: $457.67M High: $486.37M avg. 13.78% | Avg: $518.7M Low: $503.35M High: $534.91M avg. 9.97% | Avg: $543.95M Low: $527.85M High: $560.95M avg. 4.86% |
Net Income
% change YoY
| $-84.45M N/A | $-85.18M -0.86% | $-28.23M 66.84% | Avg: $127.46M Low: $103.02M High: $132.14M avg. 551.38% | Avg: $143.86M Low: $118.70M High: $145.58M avg. 12.86% | Avg: $153.05M Low: $147.16M High: $159.27M avg. 6.38% | Avg: $159.02M Low: $152.90M High: $165.48M avg. 3.90% |
EBITDA
% change YoY
| $-57.87M N/A | $-39.23M 32.20% | $5.12M 113.04% | Avg: $-236.55M Low: $-257.56M High: $-215.53M avg. -4720.21% | Avg: $-269.17M Low: $-277.59M High: $-261.20M avg. -13.78% | Avg: $-296.03M Low: $-305.29M High: $-287.27M avg. -9.97% | Avg: $-310.44M Low: $-320.15M High: $-301.26M avg. -4.86% |
EPS
% change YoY
| -$0.61 N/A | -$0.43 29.50% | -$0.13 69.76% | Avg: $0.54 Low: $0.46 High: $0.59 avg. 515.38% | Avg: $0.6 Low: $0.53 High: $0.65 avg. 11.72% | Avg: $0.68 Low: $0.66 High: $0.71 avg. 13.25% | Avg: $0.71 Low: $0.68 High: $0.74 avg. 3.90% |
Operating Expenses
% change YoY
| $59.54M N/A | $74.63M 25.32% | $66.58M -10.77% | Avg: $234.47M Low: $213.64M High: $255.30M avg. 252.13% | Avg: $266.80M Low: $258.91M High: $275.15M avg. 13.78% | Avg: $293.43M Low: $284.75M High: $302.60M avg. 9.97% | Avg: $307.71M Low: $298.61M High: $317.34M avg. 4.86% |
FAQ
What is ADMA Biologics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 143.63% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is 103.02M, average is 127.46M and high is 132.14M.
What is ADMA Biologics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.28% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $377.65M, average is $414.47M and high is $451.29M.
What is ADMA Biologics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 136.06% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is $0.46, average is $0.54 and high is $0.59.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering ADMA Biologics stock. The most successful analyst is Raghuram Selvaraju.